COVID-19 vaccine leads to higher overall antibody levels than a shorter gap, a British study found on Friday, but there is a sharp drop in antibody levels after the first dose.The study might help inform vaccination strategies against the Delta variant, which reduces the effectiveness of a first dose of COVID-19 vaccine even though two doses are still protective.
Canadian study finds mRNA vaccines produce more COVID-19 antibodies than AstraZeneca “For the longer dosing interval … neutralizing antibody levels against the Delta variant were poorly induced after a single dose, and not maintained during the interval before the second dose,” the authors of the study, which is being led by the University of Oxford, said.“Following two vaccine.
Read more on globalnews.ca